• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Pharma & Human Health

Prebiotic innovation made from prairie-grown potatoes earns FODMAP Friendly Certification as more clinical findings confirm that MSPrebiotic® helps promote a healthier gut

March 1, 2018 Microbiome Times

Prairie-grown potatoes have been enjoyed across Canada for years, and now through a patented technology a Manitoba company is transforming the popular tubers into an all-natural, single ingredient prebiotic fibre supplement that leads to improved […]

Pharma & Human Health

Second Genome Strengthens R&D Program in Immuno-Oncology with Four Academic Collaborations

February 28, 2018 Microbiome Times

Second Genome, Inc., a leader in the development of novel medicines derived from the human microbiome, today announced the initiation of four collaborations with key academic institutions to evaluate the effect of gut microbiota on […]

Finance

Synthetic Biologics Reports 2017 Year End Operational Highlights and Financial Results

February 22, 2018 Microbiome Times

Synthetic Biologics, Inc. (NYSE American: SYN), a late-stage clinical company developing therapeutics that preserve the microbiome to protect and restore the health of patients, today provided a clinical programs update and reported financial results for […]

Pharma & Human Health

Metagenics Joins the UC San Diego Center for Microbiome Innovation as an Industry Sponsor

February 5, 2018 Microbiome Times

Metagenics, Inc., a health sciences company, has joined the UC San Diego Center for Microbiome Innovation (CMI) as an industry sponsor. CMI encompasses a large range of expertise from microbiome sampling, a broad range of […]

Pharma & Human Health

BiomX Licenses Novel Bacterial Targets for the Treatment of Inflammatory Bowel Disease

January 30, 2018 Microbiome Times

NESS ZIONA, Israel, Jan. 30, 2018 /PRNewswire/ — BiomX Ltd., a microbiome company developing customized phage therapies, today announced that it has exclusively sub-licensed from JSR Corporation a set of bacterial targets for the development and […]

Posts navigation

« 1 … 84 85

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter